26S Proteasome Activity Assay

NL Na Kyung Lee
SP Sang Eon Park
SK Soo Jin Kwon
SS Sangmi Shim
YB Yeji Byeon
JK Jong-Hwa Kim
DN Duk L. Na
JC Jong Wook Chang
request Request a Protocol
ask Ask a question
Favorite

The proteasome assay was performed according to previously reported protocols42. In the absence of proteasome inhibitors, cell lysates were prepared through ultra-sonication in retic buffer (30 mM Tris (pH 7.8), 5 mM MgCl2, 5 mM KCl, 0.5 mM DTT, 2 mM ATP). In 96-well black/clear plates (BD Falcon, USA), 5 μg of the cytoplasmic proteins were treated with 200 μM of the fluorogenic substrate Suc-Leu-Leu-Val-Tyr-AMC (SUC-LLVY-AMC; Enzo, Republic of Korea) to a final concentration of 100 μM. Cytoplasmic proteins were treated with the fluorogenic substrate and incubated for up to 4 hrs at 37 °C. After the incubation period, the reaction was stopped with the addition of cold ethanol, and the fluorescence of the samples was measured at 380/460 nm (Ex/Em) using a fluorometer (Glomax, Promega, USA). The following fluorogenic substrates were obtained from Enzo and were also used in this study: Bz-Val-Gly-Arg-AMC (Bz-VGR-AMC; trypsin-like activity), Ac-Gly-Pro-Leu-Asp-AMC (Ac-GPLD-AMC; caspase-like activity), and ubiquitin-AMC (deubiquitinating activity).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A